Galectin Therapeutics Inc. (GALT) Earnings Call Transcripts

5 earnings calls from September 2020 to March 10, 2026

NasdaqCM US Health Care Biotechnology

About Galectin Therapeutics Inc.

Galectin Therapeutics Inc. (GALT) is a publicly listed company in the Biotechnology industry, within the Health Care sector. It trades on NasdaqCM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 5 calls on record spanning September 29, 2020 to March 10, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 5 Galectin Therapeutics Inc. earnings call transcripts on record, spanning September 29, 2020 to March 10, 2026. Based on this history, Galectin Therapeutics Inc. reports annually. The most recent call on file is dated March 10, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
GALT
Exchange
NasdaqCM
Country
US
Sector
Health Care
Industry
Biotechnology
Calls on record
5
First call
September 29, 2020
Most recent
March 10, 2026
Reporting cadence
annually
Quarter Date
Special Calls Mar 10, 2026 Read transcript
Special Calls Jun 16, 2025 Read transcript
Shareholder/Analyst Calls Dec 3, 2021 Read transcript
Shareholder/Analyst Calls Dec 3, 2020 Read transcript
Special Calls Sep 29, 2020 Read transcript